Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 07, 2024 16:05 ET
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced it will...
May 07, 2024 16:05 ET
Synchronoss Technologies Reports First Quarter 2024 Results
Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, today reported financial results for its first quarter ended March 31, 2024. First Quarter and Recent...
May 07, 2024 16:05 ET
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system (CNS), today announced...
May 07, 2024 16:05 ET
Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today...
May 07, 2024 16:05 ET
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based...
May 07, 2024 16:05 ET
The RealReal Announces First Quarter 2024 Results
The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today reported financial results for its first quarter ended March 31, 2024. The company returned to overall top-line growth with gross...
May 07, 2024 16:05 ET
Treace Medical Concepts Reports First Quarter 2024 Financial Results
Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and...
May 07, 2024 16:05 ET
Veeco Reports First Quarter 2024 Financial Results
Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its first quarter ended March 31, 2024. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for...
May 07, 2024 16:05 ET
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced financial results for the first quarter ended March 31,...
May 07, 2024 16:05 ET
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that Mark Rothera, President and Chief...
May 07, 2024 16:05 ET
Weyco Reports First Quarter Sales and Earnings
Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter ended March 31, 2024. First Quarter 2024 Consolidated net sales were $71.6 million, down 17% compared to record...
May 07, 2024 16:05 ET
Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the...
May 07, 2024 16:04 ET
GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
The law firm of Robbins Geller Rudman & Dowd LLP announces that the GoodRx class action lawsuit seeks to represent purchasers or acquirers of GoodRx Holdings, Inc. (NASDAQ: GDRX) common stock between September 23, 2020 and November 8, 2022, both...
May 07, 2024 16:02 ET
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AXT Inc (“AXT” or “the Company”) (NASDAQ: AXTI) and certain of its officers. Class...
May 07, 2024 16:02 ET
TPI Composites Partners with University of Maine and Oak Ridge National Laboratory to Leverage One of the World’s Largest Polymer 3D Printers for Wind Turbine Tooling
TPI Composites, Inc., (TPI) (Nasdaq: TPIC) today announced a groundbreaking initiative in partnership with the University of Maine Advanced Structures and Composites Center (ASCC) and Oak Ridge National Laboratory to utilize one of the world's...
May 07, 2024 16:02 ET
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial...
May 07, 2024 16:02 ET
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND
Marten Transport, Ltd. (Nasdaq/GS:MRTN) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.06 per share of common stock. The dividend will be payable on June 28, 2024 to stockholders of record at the...
May 07, 2024 16:01 ET
LegalZoom Reports First Quarter 2024 Financial Results
LegalZoom.com, Inc. (Nasdaq: LZ), the No. 1 choice in online small business formations, today announced results for its first quarter ended March 31, 2024. “I am excited by the momentum we are seeing across our ecosystem. We began the year with...
May 07, 2024 16:01 ET
Mercury Systems Reports Third Quarter Fiscal 2024 Results
Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), reported operating results for the third quarter of fiscal year 2024, ended March 29, 2024. “In the third quarter of fiscal year 2024, we made solid progress in each of our four priority focus...
May 07, 2024 16:01 ET
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced its financial results for the first quarter of 2024 and provided a...